Home › Steatotic Liver Disease › Ohio › Dayton

Pag-aaral pangklinika para sa Steatotic Liver Disease sa Dayton, OH

Isang pag-aaral para sa Steatotic Liver Disease ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dayton. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Nagre-recruitPhase 3

89bio Clinical Study Site, Dayton
89bio Clinical Study Site, Dayton

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Nagre-recruitPhase 3

89bio Clinical Study Site, Dayton
89bio Clinical Study Site, Dayton
89bio Clinical Study Site, Springboro · 14 mi ang layo

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Nagre-recruitPhase 3

GSK Investigational Site, Springboro · 14 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07704892

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Nagre-recruitPhase 3

Dayton Gastroenterology - Beavercreek, Beavercreek · 8 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Nagre-recruitPhase 3

Akero Clinical Study Site, Springboro · 14 mi ang layo

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Nagre-recruitPhase 3

GSK Investigational Site, Springboro · 14 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Nagre-recruitPhase 2

Digestive Specialists, Dayton
DSI Research, Springboro · 14 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07288138

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Nagre-recruitPhase 3

GSK Investigational Site, Springboro · 14 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT07221227

Pag-aaral para sa Steatotic Liver Disease sa ibang lungsod

Iba pang pag-aaral sa Dayton

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.